The Latest Cardiac and Vascular News
WARRINGTON, Pa., Aug. 05, 2021 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported financial results for the second quarter ended June 30, 2021 and provided key business updates. “I am […]
Conference call begins today at 4:30 p.m. Eastern Time BASKING RIDGE, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, provides a corporate update and reports financial results […]
–Walmart, Walgreens, Rite Aid, CVS and many other retailers placing VAZALORE on shelves later this month– –VAZALORE launch inventory manufactured and currently shipping to retailers across the country– SPARTA, N.J., Aug. 06, 2021 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company focused […]
– Phase 3 ELEVATE UC 12 trial reached full enrollment; topline data expected Q1 2022 with ELEVATE UC 52 – Liquidity position at ~$1.0 billion as of June 30, 2021 to support continued pipeline progress PARK CITY, Utah–(BUSINESS WIRE)–Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported […]
Q2 GAAP revenue including Grant Revenue $25.4M; Q2 Non-GAAP revenue $24.4M, an increase of 86% over prior year; instrument placements up 71% BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the three months ending June 30, 2021. […]
– Highlighted ongoing and planned trials in rare pulmonary diseases and presented vision and strategy for long-term growth at June R&D Day – – Updates from the PULSAR and SPECTRA Phase 2 trials of sotatercept in patients with pulmonary arterial hypertension (PAH) presented at the American Thoracic Society (ATS) 2021 […]
FRANKLIN LAKES, N.J., Aug. 5, 2021 /PRNewswire/ — Third fiscal quarter revenues of $4.9 billion grew 26.9% on a reported basis. On a currency-neutral basis, revenues increased 22.0%. BD’s COVID-19 testing revenues were $300 million, including BD Veritor™ Plus System revenues of $212 million. Third fiscal quarter GAAP diluted earnings per share (EPS) increased 77.3% year-over-year […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the appointment of John Farquhar as Chief Operating Officer, effective August 4. In this newly established role, Mr. Farquhar will support the execution of HeartFlow’s strategic vision. “We are thrilled to add an executive of John’s […]
Conference Call Scheduled for Today, August 4, 2021, at 3:30 PM CT (4:30 PM ET) Revenues of $71.0 million increased 66.8% compared to fourth quarter last year and increased 12.2% sequentially compared to third quarter this year Fiscal 2021 revenues increased 9.5% to a record high $259 million Management provides […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced second quarter 2021 financial results. “Our second quarter results were driven by outperformance across our business, as strong underlying demand returned and we saw continued progress toward making […]
